Skip to content
AZBio Logo
  • Members
    • AZBio Member Directory
      • Member Login
    • Join AZBio
    • Support AZBio
    • Save with AZBio Purchasing Power
  • AZBio News
    • Voice of the Patient
    • Resources for Media
      • 3rd Party Content
  • Events
    • AZBio Trailblazers Luncheon
    • 2026 State Bio Friends Reception
    • Arizona Bioscience Week 2026
      • Looking Back at AZBW 2025
      • Looking Back at AZBW 2024
    • AZBio Day at The Capitol
  • Advocacy
    • AZBio Legislative Watch List for 2026
    • Request to Speak Instructions
    • AZBio Public Policy Principles
    • Arizona Congressional Delegation
    • 2026 Congressional Calendar
  • Resources
    • AZBioPEERS
    • AZBio PEERS Mentoring Program
    • Cost Saving Programs
    • Core Facilities
    • Arizona Life Science Infrastructure
    • Clinical Trials in Arizona
    • AZBio Career Center
    • Arizona BioMap
  • About AZBio
    • What We Do
    • AZBio Board of Directors
    • AZBio Staff
    • Arizona Bioindustry Fact Sheet
    • AZBio History
  • Menu

Author Archive: AZBio

C-Path, CHDI Foundation, and CDISC Announce Public Review Period for Huntington’s Disease Therapeutic Area User Guide

Posted on Mon/11/SeptemberMon/11/September by AZBio

The TAUG-HD v1.0 describes how HD clinical data should be recorded in a standardized database to establish common best practices across the healthcare industry for the recording, reporting, and sharing of clinically relevant disease-specific metadata, research data, and patient information. Continue reading→

Hiring Hints from the AZBio Career Center

Posted on Fri/8/SeptemberFri/8/September by AZBio

The AZBio Career Center  is the go-to channel for recruitment!Continue reading→

New Data on Castle Biosciences DecisionDx-Melanoma Gene Expression Profile Test

Posted on Thu/7/SeptemberThu/7/September by AZBio
  • New Publication Highlights First Prospective Performance Assessment of the DecisionDx-Melanoma Gene Expression Profile Test
  • Multi-center study of 322 patients confirms prognostic accuracy and performance 

Continue reading→

New Director to Lead Informatics Fellowship at UA College of Medicine Phoenix

Posted on Thu/7/SeptemberThu/7/September by AZBio

Hamed Abbaszadegan, MD, MBA, will lead the Clinical Informatics Fellowship with Plans to Revolutionize Health Care Through Information TechnologyContinue reading→

SinfoníaRx Acquired by Tabula Rasa HealthCare Inc

Posted on Thu/7/SeptemberFri/8/September by AZBio

Spun out as a UA startup company in 2013, SinfoníaRx pioneered modern medication therapy management services and has now been purchased by Tabula Rasa HealthCare Inc.Continue reading→

ASU a key player in Arizona Wellbeing Commons, an umbrella group that aims to tackle complex disease issues

Posted on Thu/7/SeptemberThu/7/September by AZBio

Arizona State University is a key player in a new health research initiative designed to harness the expertise of scientists across the state to treat diseases like cancer and address such problems as unequal access to health care.Continue reading→

Midwestern University researchers discover previously unknown cause of nTOS

Posted on Wed/6/SeptemberWed/6/September by AZBio

Findings also show efficacy of ultrasound diagnostics in revealing brachial plexus piercing variations in subjects with nTOS symptoms

Continue reading→

TGen launchs new high school science program

Posted on Tue/5/SeptemberThu/7/September by AZBio

The Translational Genomics Research Institute (TGen) and Helios Education Foundation today announced the formation of a new biomedical studies program designed specifically for high school students to elevate their understanding of bioscience and precision medicine. (Republished with permission. Posted September 5, 2017 by AZ Business Magazine ) 

Continue reading→

AZBio In The Loop for the Week of Sept 5 2017

Posted on Mon/4/SeptemberSun/10/June by AZBio

Continue reading→

UA Team Tackles Better Brain Health

Posted on Mon/4/SeptemberMon/4/September by AZBio

A trial will look at whether a naturally occurring compound, known as angiotensin 1-7, relieves cognitive deficits after heart bypass. The UA collaborators include a cardiologist, a physiologist and a psychologist.

Continue reading→

Post navigation

« Previous 1 … 199 200 201 202 203 204 205 206 207 208 209 … 393 Next »

Blog Categories

Upcoming Events

  • 2026 State Bio Friends Reception
            Jan 11, 2026 - San Francisco
  • Biotech Showcase 2026
            Jan 12, 2026 - San Francisco
  • RESI at JPM
            Jan 12, 2026 - San Francisco
  • BIO Partnering at JPM Week
            Jan 12, 2026 -
  • AZBio 2026 Kickoff at Clayco
            Jan 22, 2026 - Phoenix
  • AZBio Day at The Capitol
            Feb 18, 2026 - Phoenix
  • 2026 Flinn Bio Capital Conference
            Mar 5, 2026 - Phoenix
  • 2026 Flinn Foundation Bio Capital Conference
            Mar 5, 2026 - Phoenix
  • Children's Health Advocacy Day 2026
            Mar 23, 2026 - Phoenix
  • Arizona Tech Week - April 6-12
            Apr 6, 2026 -
  • AZAdvances Health Innovation Showcase - AZTECH WEEK
            Apr 7, 2026 - Phoenix
  • World Parkinson Conference - WPC 2026 Phoenix
            May 24, 2026 - Phoenix
  • BIO International Convention
            Jun 22, 2026 - San Diego
  • all events

Blog Archive

  • Click the image for the latest news about AZBio Members
  • Click the image to learn more about AZBio Membership
  • Click the image to learn more
  • Click the image to learn more
  • Click the image to enter the AZBio Career Center 
  • Click the image to learn more
  • Click the image to learn more
  • Patients are why we do what we do. Click the image to listen to their stories.

Disclaimer
Imprint
Cookie Policy (CA)
Privacy Policy (CA)

Copyright 2025 | Arizona Bioindustry Association, Inc.
A SiteOrigin Theme
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}
Manage Cookie Consent
We use cookies to optimize our website and our service.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}